scholarly journals Comparison of SARS-CoV-2 infections among 3 species of non-human primates

2020 ◽  
Author(s):  
Shuaiyao Lu ◽  
Yuan Zhao ◽  
Wenhai Yu ◽  
Yun Yang ◽  
Jiahong Gao ◽  
...  
Keyword(s):  
Histopathological Examination ◽  
Clinical Signs ◽  
Post Inoculation ◽  
New World Monkeys ◽  
Viral Genomes ◽  
Viral Shedding ◽  
Nasal Swabs ◽  
Gross Lesions ◽  
Upper Respiratory ◽  
Human Primate

AbstractCOVID-19, caused by SARS-CoV-2 infection, has recently been announced as a pandemic all over the world. Plenty of diagnostic, preventive and therapeutic knowledges have been enriched from clinical studies since December 2019. However, animal models, particularly non-human primate models, are urgently needed for critical questions that could not be answered in clinical patients, evaluations of anti-viral drugs and vaccines. In this study, two families of non-human primates, Old world monkeys (12 Macaca mulatta, 6 Macaca fascicularis) and New world monkeys (6 Callithrix jacchus), were experimentally inoculated with SARS-CoV-2. Clinical signs were recorded. Samples were collected for analysis of viral shedding, viremia and histopathological examination. Increased body temperature was observed in 100% (12/12) M. mulatta, 33.3% (2/6) M. fascicularis and none (0/6) of C. jacchus post inoculation of SARS-CoV-2. All of M. mulatta and M. fascicularis showed chest radiographic abnormality. Viral genomes were detected in nasal swabs, throat swabs, anal swabs and blood from all 3 species of monkeys. Viral shedding from upper respiratory samples reached the peak between day 6 and day 8 post inoculation. From necropsied M. mulatta and M. fascicularis, the tissues showing virus positive were mainly lung, weasand, bronchus and spleen. No viral genome was seen in any of tissues from 2 necropsied C. jacchus. Severe gross lesions and histopathological changes were observed in lung, heart and stomach of SARS-CoV-2 infected animals. In summary, we have established a NHP model for COVID-19, which could be used to evaluate drugs and vaccines, and investigate viral pathogenesis. M. mulatta is the most susceptible to SARS-CoV-2 infection, followed by M. fascicularis and C. jacchus.One Sentence SummaryM. mulatta is the most susceptible to SARS-CoV-2 infection as compared to M. fascicularis and C. jacchus.

scholarly journals Infectious SARS-CoV-2 is emitted in aerosols

2021 ◽  
Author(s):  
Seth A. Hawks ◽  
Aaron J. Prussin ◽  
Sarah C. Kuchinsky ◽  
Jin Pan ◽  
Linsey C. Marr ◽  
...  
Keyword(s):  
Direct Evidence ◽  
Infectious Virus ◽  
Emission Rate ◽  
Clinical Signs ◽  
Respiratory Viruses ◽  
Post Inoculation ◽  
Viral Shedding ◽  
Contact Transmission ◽  
Respiratory Droplets ◽  
Kinetics Of

Respiratory viruses such as SARS-CoV-2 are transmitted in respiratory droplets and aerosols, which are released during talking, breathing, coughing, and sneezing. Non-contact transmission of SARS-CoV-2 has been demonstrated, suggesting transmission in aerosols. Here we demonstrate that golden Syrian hamsters emit infectious SARS-CoV-2 in aerosols, prior to and concurrent with the onset of mild clinical signs of disease. The emission rate is 25 infectious virions/hour on days 1 and 2 post-inoculation, with viral RNA levels 200-fold higher than infectious virus in aerosols. Female hamsters have delayed kinetics of viral shedding in aerosols compared to male hamsters. The majority of virus is contained within aerosols <8 microns in size. Thus, we provide direct evidence that, in hamsters, SARS-CoV-2 is an airborne virus.

scholarly journals Genetic and antigenic characteristics of H4 subtype avian influenza viruses in Korea and their pathogenicity in quails, domestic ducks and mice

2013 ◽  
Vol 94 (1) ◽  
pp. 30-39 ◽  
Author(s):  
Hyun-Mi Kang ◽  
Jun-Gu Choi ◽  
Kwang-Il Kim ◽  
Ha-Young Park ◽  
Choi-Kyu Park ◽  
...  
Keyword(s):  
Avian Influenza ◽  
Clinical Signs ◽  
Significant Loss ◽  
Wild Birds ◽  
Influenza Viruses ◽  
Post Inoculation ◽  
Avian Influenza Viruses ◽  
Domestic Ducks ◽  
Viral Shedding ◽  
Nationwide Surveillance

In Korea, a nationwide surveillance programme was implemented in 2003 to identify highly pathogenic avian influenza viruses (AIVs). AIVs belonging to one of the most common haemagglutinin subtypes, H4, were isolated from two domestic ducks and 52 wild birds between 2004 and 2010. These H4 AIVs could be further classified into three neuraminidase subtypes: H4N6 (94.4 %), H4N2 (3.7 %) and H4N3 (1.9 %). Phylogenetic analysis revealed that the H4 AIVs had a variety of genetic constellations, with at least nine different genotypes represented. The pathogenicity of these H4 viruses was assessed in quails, domestic ducks and mice. None of the H4 AIVs induced clinical signs in quails or domestic ducks. Viral shedding in quails was relatively high, and virus was recovered up to 5–7 days post-inoculation (p.i.) in oropharyngeal swabs, but the viruses replicated poorly in domestic ducks. Quails may act as an intermediate host in which AIVs are amplified and transmitted to other species. In mice, all of the AIVs were recovered efficiently at relatively high titres from the lungs up to 7 days p.i., demonstrating the potential for AIVs to infect mice directly without prior adaptation. None of the AIVs induced clinical signs nor was any lethal to infected mice. However, there was significant loss of body weight in mice infected with viruses of duck origin. It is suggested that the active surveillance of influenza viruses needs to be enhanced in domestic poultry as well as in wild birds, and that it should include assessment of pathogenicity in animal models.

scholarly journals Prophylactic and therapeutic effects of twice-daily famciclovir administration on infectious upper respiratory disease in shelter-housed cats

2018 ◽  
Vol 21 (6) ◽  
pp. 544-552 ◽  
Author(s):  
Ann E Cooper ◽  
Sara M Thomasy ◽  
Tracy L Drazenovich ◽  
Philip H Kass ◽  
Sanskruti S Potnis ◽  
...  
Keyword(s):  
Respiratory Disease ◽  
Clinical Signs ◽  
Pathogen Transmission ◽  
Controlled Study ◽  
Therapeutic Effects ◽  
Viral Shedding ◽  
Feline Herpesvirus ◽  
Upper Respiratory ◽  
Clinically Significant ◽  
Therapeutic Study

Objectives In humans with herpetic disease, early or pre-emptive famciclovir therapy reduces disease duration and severity. This prospective, masked, placebo-controlled study tested therapeutic and prophylactic effects of two famciclovir doses given to cats for 7 days following shelter entry. Methods Cats were assigned to prophylactic or therapeutic study arms based on clinical evidence of herpetic disease at study entry. Cats in the therapeutic arm received no treatment (n = 19), placebo (lactose; n = 18) or famciclovir at ~30 (n = 21) or ~90 mg/kg (n = 20) PO q12h for 7 days. Cats in the prophylactic arm received no treatment (n = 25) or famciclovir at ~30 (n = 28) or ~90 mg/kg (n = 27) PO q12h for 7 days. Disease scores, body weight, conjunctival feline herpesvirus 1 (FHV-1) shedding, and adoption rates were recorded on days 1 (admission), 8 (end of therapy) and 15 (1 week after cessation of therapy). Results No significant differences in clinical scores were observed among groups in the prophylactic or therapeutic arms at any of the three time points. However, within the therapeutic arm, viral shedding on day 8 was significantly higher in cats receiving no treatment than in those receiving ~30 or ~90 mg/kg famciclovir, and this effect persisted 1 week after famciclovir was stopped (day 15) only in cats receiving ~30 mg/kg, although this approached significance in cats receiving ~90 mg/kg. No significant differences in adoption rates were detected among groups in either arm throughout the study. Conclusions and relevance Although we did not demonstrate a statistically or clinically significant effect of famciclovir administration upon clinical signs of infectious upper respiratory disease or adoption, when it was administered at ~30 or ~90 mg/kg q12h for 1 week famciclovir reduced conjunctival FHV-1 shedding. This suggests a potential role in interrupting the infectious cycle within a shelter population; however, cost in time and resources, and stress and pathogen transmission induced by oral administration should be considered.

scholarly journals Comparative pathogenicity of bovine herpesvirus 1 (BHV-1) subtypes 1 (BHV-1.1) and 2a (BHV-1.2a)

2004 ◽  
Vol 24 (1) ◽  
pp. 43-49 ◽  
Author(s):  
Fernando Rosado Spilki ◽  
Paulo Augusto Esteves ◽  
Marcelo de Lima ◽  
Ana Cláudia Franco ◽  
Cláudio Chiminazzo ◽  
...  
Keyword(s):  
Respiratory Disease ◽  
Nasal Mucosa ◽  
Clinical Signs ◽  
Bovine Herpesvirus ◽  
Restriction Enzyme Digestion ◽  
Post Inoculation ◽  
Virus Shedding ◽  
Herpesvirus Type ◽  
Viral Genomes ◽  
Significant Difference

The study aimed to examine the capacity of two bovine herpesvirus type 1 (BHV-1) isolates of different subtypes (EVI 123/96, BHV-1.1; SV265/98, BHV-1.2a) to induce respiratory disease in calves. These two isolates are representative of the BHV-1 subtypes prevalent in Brazil. Viral subtypes were confirmed by monoclonal antibody analysis and by restriction enzyme digestion of viral genomes. The viruses were inoculated intranasally into seven 3 months old calves (four with BHV-1.1, three with BHV-1.2a). Three other calves of identical age and condition were kept as uninfected controls. In both groups of infected calves, the clinical signs observed were consistent with typical infectious bovine rhinothracheitis (IBR), including pyrexia, apathy, anorexia, nasal and ocular mucopurulent discharges, erosions on the nasal mucosa, conjunctivitis, lachrymation, redness of nasal mucosa, dyspnoea, coughing, tracheal stridor and enlargement of retropharingeal, submandibular and cervical lymphnodes. No significant differences were observed between the clinical scores attributed to both groups. Virus shedding in nasal and ocular secretions were also similar, apart from a significant difference in nasal virus shedding on day 1 to 3 post-inoculation, which was higher for BHV-1.1 than for BHV-1.2a. Following corticosteroid induced reactivation of the latent infection, recrudescence of clinical signs was also observed, with no significant differences on both groups. It was concluded that both subtypes BHV-1.1 and BHV-1.2a were able to induce clinically undistinguishable respiratory disease in calves, either subsequent to a primary infection or following reactivation.

scholarly journals Intranasal ChAdOx1 nCoV-19/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical models

2021 ◽  
pp. eabh0755
Author(s):  
Neeltje van Doremalen ◽  
Jyothi N. Purushotham ◽  
Jonathan E. Schulz ◽  
Myndi G. Holbrook ◽  
Trenton Bushmaker ◽  
...  
Keyword(s):  
Respiratory Tract ◽  
Direct Contact ◽  
Infectious Virus ◽  
Rhesus Macaques ◽  
Upper Respiratory Tract ◽  
Preclinical Models ◽  
Viral Loads ◽  
Viral Shedding ◽  
Nasal Swabs ◽  
Upper Respiratory

ChAdOx1 nCoV-19/AZD1222 is an approved adenovirus-based vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) currently being deployed globally. Previous studies in rhesus macaques revealed that intramuscular vaccination with ChAdOx1 nCoV-19/AZD1222 provided protection against pneumonia but did not reduce shedding of SARS-CoV-2 from the upper respiratory tract. Here, we investigated whether intranasally administered ChAdOx1 nCoV-19 reduces detection of virus in nasal swabs after challenging vaccinated macaques and hamsters with SARS-CoV-2 carrying a D614G mutation in the spike protein. Viral loads in swabs obtained from intranasally vaccinated hamsters were decreased compared to control hamsters, and no viral RNA or infectious virus was found in lung tissue after a direct challenge or after direct contact with infected hamsters. Intranasal vaccination of rhesus macaques resulted in reduced virus concentrations in nasal swabs and a reduction in viral loads in bronchoalveolar lavage and lower respiratory tract tissue. Intranasal vaccination with ChAdOx1 nCoV-19/AZD1222 reduced virus concentrations in nasal swabs in two different SARS-CoV-2 animal models, warranting further investigation as a potential vaccination route for COVID-19 vaccines.

scholarly journals The immune response does not prevent homologous Porcine epidemic diarrhoea virus reinfection five months after the initial challenge.

2021 ◽  
Author(s):  
Ivan Díaz ◽  
Joan Pujols ◽  
Esmeralda Cano ◽  
Marti Cortey ◽  
Núria Navarro ◽  
...  
Keyword(s):  
Immune Response ◽  
Clinical Signs ◽  
Second Phase ◽  
Post Inoculation ◽  
Viral Shedding ◽  
Porcine Epidemic Diarrhoea Virus ◽  
Diarrhoea Virus ◽  
Group A ◽  
Ifn Γ ◽  
Group B

The aim of the present study was to evaluate the duration of protective immunity against Porcine epidemic diarrheoa virus (PEDV). To that, a two phases study was performed. In the first phase, 75 four-week-old pigs (group A) were orally inoculated (0 days post-inoculation; dpi) with a European PEDV G1b strain and 14 were kept as controls (group B). The second phase started five month later (154 dpi), when animals in group A were homologous challenged and animals in group B were challenged for first time. Clinical signs, viral shedding and immune responses were evaluated after each inoculation, including the determination of antibodies (ELISA and viral neutralisation test, IgA and IgG ELISPOTs using peripheral blood mononuclear cells and lymph node cells) and the frequency of interferon-gamma (IFN-γ) secreting cells. During the first phase, loose stools/liquid faeces were observed in all group A animals. Faecal shedding of PEDV occurred mostly during the first 14 days but, in some animals, persisted until 42 dpi. All inoculated animals seroconverted for specific-PEDV IgG and IgA, and for neutralizing antibodies (NA). At 154 dpi, 77% of pigs were still positive for NA. After that, the homologous challenge resulted in a booster for IgG, IgA, NA, as well as specific-PEDV IgG, IgA and IFN-γ secreting cells. In spite of that, PEDV was detected in faeces of all pigs from group A, indicating that the immune response did not prevent reinfection although the duration of the viral shedding and the total load of virus shed was significantly lower for previously challenged pigs (p<0.05). Taken together, the results indicated that, potentially, maintenance of PEDV infection within an endemic farm may occur by transmission to and from previously infected animals and also indicates that sterilising immunity is shorter than the productive life of pigs.

scholarly journals Clinico-Pathological Investigation of Chicken Coccidiosis at Different Upazila in Bogura District

2020 ◽  
Vol 7 (2) ◽  
pp. 267-274
Author(s):  
Md Mofizul Islam ◽  
Md Haydar Ali ◽  
Md Nazrul Islam ◽  
Mahfuza Akther ◽  
Md Gausur Rahman
Keyword(s):  
Histopathological Examination ◽  
Clinical Signs ◽  
Management Program ◽  
Intestinal Lumen ◽  
Small Scale ◽  
Age Group ◽  
Poultry Farms ◽  
Proportional Mortality ◽  
Commercial Poultry ◽  
Gross Lesions

The experiment was conducted with the interest to know the overall condition of coccidiosis in small scale commercial poultry farms at different upazilla in Bogura district and the investigation was done from July to December, 2018. A thorough clinical and necropsy examination was done for characterizing the clinical signs, recording of gross lesions and collection of different organs mainly the small intestine and the caecum for further histopathological examination. A total of 343 suspected and dead chickens were examined, among them 52 (15.38%) (20.6% in broiler, 10.47% in sonali, 10.25% in layer) chickens were found positive for chicken coccidiosis. The proportional mortality rates were 19.25%, 21.42%, 8.23% and 7.5% respectively in age group of 0-4 weeks, 5-6 weeks, 7-8 weeks and above 8 weeks and the highest value was found in age group of 5- 6 weeks. Depression, ruffled feather, bloody diarrhoea, anaemia, drooping of wings and reduction of feed and water intake were commonly observed. Several gross changes were recorded including enlargement and discoloration of caecum, pinkish or blood mixed catarrhal contents in the intestinal lumen with numerous haemorrhagic lesions over intestinal mucosa. Histopathologically there was architectural destruction of caecum, destroyed and disorganized villi mucosa without any continuation of the lining epithelium. Some facts like farmers knowledge, the bio-safety measures and different protection programs with vaccination against the disease did not properly comply with the approved standards. Thus consideration of such points in management program of coccidiosis can improve the poultry farms of Bogura district. Res. Agric., Livest. Fish.7(2): 267-274,  August 2020

scholarly journals Comparison of the Pathogenicity of Two Different Branches of Senecavirus a Strain in China

Pathogens ◽  
2020 ◽  
Vol 9 (1) ◽  
pp. 39 ◽  
Author(s):  
Huawei Zhang ◽  
Pin Chen ◽  
Genxi Hao ◽  
Wenqiang Liu ◽  
Huanchun Chen ◽  
...  
Keyword(s):  
Neutralizing Antibodies ◽  
Nasal Swab ◽  
Clinical Signs ◽  
Particle Morphology ◽  
Post Inoculation ◽  
Finishing Pigs ◽  
Plaque Size ◽  
Viral Shedding ◽  
Different Strains ◽  
Vesicular Disease

Senecavirus A (SVA), an emerging infectious disease, is associated with the porcine idiopathic vesicular disease. Here, the pathogenesis of different strains of SVA was investigated in growing-finishing pigs. We aimed to evaluate the replication characteristics, virus particle morphology, clinical signs, and vesicular lesions in comparison with two different strains of SVA. The animals were infected with SVA HB-CH-2016 or CH/AH-02/2017 by intranasal routes (3 mL, 109TCID50/mL) and monitored daily for 14 days post-inoculation (dpi) for clinical signs and vesicular lesions. Viremia or viral shedding was detected in the blood, fecal swab, and nasal swab samples. Results showed no distinct differences in plaque size, replication ability, and characteristic virions between SVA HB-CH-2016 and CH/AH-02/2017 strains. Animal experimental results showed that both SVA CH/AH-02/2017 and SVA HB-CH-2016 could infect pigs. However, an obvious difference in the pathogenicity and dynamics of infection was observed between SVA HB-CH-2016 and CH/AH-02/2017 strains. The pathogenesis of SVA CH/AH-02/2017 was similar to that of published results of USA strains, whereas the SVA HB-CH-2016 strain had low pathogenicity to pigs. Clinical signs and vesicular lesions were observed in SVA CH/AH-02/2017-infected pigs. Additionally, the different branches of SVA should be capable of inducing broad cross-reactive neutralizing antibodies, which play an important role in clearing the SVA virus. This study of animal models for SVA infection will be beneficial to develop vaccines and antivirals.

Pathogenicity and immune response against porcine circovirus type 3 infection in caesarean-derived, colostrum-deprived pigs

2020 ◽  
Author(s):  
Gun Temeeyasen ◽  
Shay Lierman ◽  
Bailey L. Arruda ◽  
Rodger Main ◽  
Fabio Vannucci ◽  
...  
Keyword(s):  
Cellular Response ◽  
Clinical Signs ◽  
Humoral Response ◽  
T Cell Response ◽  
Porcine Circovirus ◽  
Histological Evaluation ◽  
Tissue Homogenate ◽  
Post Inoculation ◽  
Viral Shedding

Recently, a novel PCV species (PCV3) has been detected in cases associated with sow mortality, lesions consistent with porcine dermatitis and nephropathy syndrome, reproductive failure and multisystemic inflammation. The pathogenesis and clinical significance of PCV3 is still unclear. In this study, we investigated the immunopathogenesis of PCV3 in CD/CD pigs. Four treatment groups, PCV3 (n=6), PCV3-KLH (n=6), control (n=3) and control-KLH (n=3), were included with PCV3-positive tissue homogenate (gc=3.38×1012 ml−1 and gc=1.04×1011 ml−1), confirmed by quantitative PCR (qPCR) and next-generation sequencing. Clinical signs, viremia, viral shedding, systemic cytokines, humoral (IgG) and T-cellular response were evaluated for 42 days. At necropsy, tissues were collected for histological evaluation and PCV3 detection by qPCR and in situ hybridization. No significant clinical signs were observed through the study. Viremia was detected in both PCV3-inoculated groups from 3 days post-inoculation (p.i.) until the end of the study. Nasal shedding was detected from 3 to 28 days p.i. and faecal shedding was transient. PCV3 induced an early (7 days p.i.) and sustained (42 days p.i.) IgG response. No significant T-cell response was observed. Histological evaluation demonstrated lesions consistent with multisystemic inflammation and perivasculitis. All tissues evaluated were positive by qPCR and virus replication was confirmed by positive in situ hybridization. This study demonstrated the potential role of PCV3 in subclinical infection, producing a mild, multisystemic inflammatory response, prolonged viremia detectable for 42 days p.i., presence of IgG humoral response and viral shedding in nasal secretions. More research is required to understand and elucidate potential co-factors necessary in the manifestation and severity of clinical disease.

HoBi-like viruses – the typical ‘atypical bovine pestivirus’

2015 ◽  
Vol 16 (1) ◽  
pp. 64-69 ◽  
Author(s):  
Fernando V. Bauermann ◽  
Julia F. Ridpath
Keyword(s):  
Clinical Signs ◽  
Respiratory Illness ◽  
Low Grade ◽  
Diarrhea Virus ◽  
Viral Shedding ◽  
Acute Infections ◽  
Clinical Presentations ◽  
Nasal Swabs ◽  
Surveillance Programs ◽  
Viral Diarrhea Virus

AbstractHoBi-like viruses, also referred to as bovine viral diarrhea virus 3 (BVDV-3) and atypical pestivirus, have been proposed as a new putative bovine pestivirus species. These viruses were first identified in the last decade and are currently distributed in at least three continents. Published findings suggest that these viruses may be endemic at least in parts of South America and Asia. The clinical presentations in cattle, described in field outbreaks and controlled studies, are similar to those associated with BVDV and range from subclinical to mild clinical signs, sporadically associated with reproductive losses, respiratory illness and hemorrhagic syndrome. The complete host range of HoBi-like virus is unknown, but data suggest higher adaptation of HoBi-like viruses to ruminants than swine. Acute infections, characterized by mild clinical signs, such as low-grade pyrexia and leukopenia, have been observed in both cattle and sheep. Virus has been isolated from nasal swabs indicating that virus was being shed. While seroconversion has been observed in pigs, no clinical presentation or viral shedding was evident following inoculation. While some commercial BVDV diagnostic tests may detect HoBi-like viruses, these tests do not differentiate between BVDV and HoBi-like viruses. The differentiation of BVDV and HoBi-like viruses is critical to the design of surveillance programs for these viruses.

Sign in / Sign up

Export Citation Format

Share Document